H.R.4906: Insulin Price Reduction Act

About This Bill

  • This bill was introduced in the 116th Congress
  • This bill is primarily about health
  • Introduced Oct. 29, 2019
  • Latest Major Action Oct. 30, 2019

Bill Version

Bill Summary

Insulin Price Reduction Act This bill prohibits health insurance plan issuers and pharmacy benefits managers (PBMs) from receiving rebates or discounts for insulin from manufacturers who certify that its current insulin list price has been reduced to an amount no greater than what the list price was for the same insulin on July 1, 2006. This restriction does not apply to discounts provided to insurance plan holders at retail sale or to...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 2 statements associated with H.R.4906.

Bill Actions

Date Description
Oct. 30, 2019
Referred to the Subcommittee on Health.
Oct. 29, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct. 29, 2019

Introduced in the House by Diana DeGette (D-Colo.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page